Molecular testing prior to first-line therapy in patients with stage IV nonsquamous non-small cell lung cancer (NSCLC): A survey of U.S. medical oncologists.
Mark R. Green
No relevant relationships to disclose
Joanne Willey
No relevant relationships to disclose
Arden Buettner
No relevant relationships to disclose
Maria Lankford
No relevant relationships to disclose
Doug B. Neely
No relevant relationships to disclose
Suresh S. Ramalingam
No relevant relationships to disclose